Induced pluripotent stem cell–derived hematopoietic stem and progenitor cells induce mixed chimerism and donor-specific allograft tolerance

• Published in: American journal of transplantation Vol. 23; no. 9; pp. 1331 - 1344
• Main Authors: Murata, Tomoki, Hama, Naoki, Kamatani, Tomoki, Mori, Akihiro, Otsuka, Ryo, Wada, Haruka, Seino, Ken-ichiro
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2023
• Subjects: iPS cell; mixed chimerism; tolerance induction; LN; MDSC; Luc-iPSC; MHC; tolerance induction; FACS; iHSPC; GFP; MFI; TPO; HSD; HSC; TBI; PBL; EB; 4-HT; CB; HSPC; KL; PSC; mixed chimerism; KSL; PMA; iPSC; Treg; mAb; B6; iPS cell; SCF; HE; NK
• ISSN: 1600-6135; 1600-6143; 1600-6143
• DOI: 10.1016/j.ajt.2023.05.020

In transplantation using allogeneic induced pluripotent stem cells (iPSCs), strategies focused on major histocompatibility complexes were adopted to avoid immune rejection. We showed that minor antigen mismatches are a risk factor for graft rejection, indicating that immune regulation remains one of the most important issues. In organ transplantation, it has been known that mixed chimerism using donor-derived hematopoietic stem/progenitor cells (HSPCs) can induce donor-specific tolerance. However, it is unclear whether iPSC-derived HSPCs (iHSPCs) can induce allograft tolerance. We showed that 2 hematopoietic transcription factors, Hoxb4 and Lhx2, can efficiently expand iHSPCs with a c-Kit+Sca-1+Lineage− phenotype, which possesses long-term hematopoietic repopulating potential. We also demonstrated that these iHSPCs can form hematopoietic chimeras in allogeneic recipients and induce allograft tolerance in murine skin and iPSC transplantation. With mechanistic analyses, both central and peripheral mechanisms were suggested. We demonstrated the basic concept of tolerance induction using iHSPCs in allogeneic iPSC-based transplantation.